JP2023523872A5 - - Google Patents
Info
- Publication number
- JP2023523872A5 JP2023523872A5 JP2021577862A JP2021577862A JP2023523872A5 JP 2023523872 A5 JP2023523872 A5 JP 2023523872A5 JP 2021577862 A JP2021577862 A JP 2021577862A JP 2021577862 A JP2021577862 A JP 2021577862A JP 2023523872 A5 JP2023523872 A5 JP 2023523872A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962868190P | 2019-06-28 | 2019-06-28 | |
| US62/868,190 | 2019-06-28 | ||
| PCT/US2020/039621 WO2020264161A1 (en) | 2019-06-28 | 2020-06-25 | Method of reconstituting liposomal annamycin |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023523872A JP2023523872A (ja) | 2023-06-08 |
| JPWO2020264161A5 JPWO2020264161A5 (https=) | 2023-07-14 |
| JP2023523872A5 true JP2023523872A5 (https=) | 2023-07-14 |
| JP7830131B2 JP7830131B2 (ja) | 2026-03-16 |
Family
ID=74061076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021577862A Active JP7830131B2 (ja) | 2019-06-28 | 2020-06-25 | リポソーム化アナマイシンを再構成する方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US12257262B2 (https=) |
| EP (1) | EP3990041B1 (https=) |
| JP (1) | JP7830131B2 (https=) |
| KR (1) | KR20220027941A (https=) |
| CN (2) | CN114728101B (https=) |
| AU (2) | AU2020302784A1 (https=) |
| BR (1) | BR112021026480A2 (https=) |
| CA (1) | CA3144443A1 (https=) |
| ES (1) | ES3049663T3 (https=) |
| IL (1) | IL289433B1 (https=) |
| MX (1) | MX2021015667A (https=) |
| PL (1) | PL3990041T3 (https=) |
| SG (1) | SG11202113005SA (https=) |
| TW (2) | TW202500161A (https=) |
| WO (1) | WO2020264161A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES3049663T3 (en) | 2019-06-28 | 2025-12-17 | Univ Texas | Method of reconstituting liposomal annamycin |
| KR20220027969A (ko) | 2019-06-28 | 2022-03-08 | 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 | 프리리포솜 아나마이신 동결건조물의 제조 |
| KR20220103992A (ko) * | 2019-11-21 | 2022-07-25 | 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 | 리포솜 아나마이신에 의한 폐 표적화 항암 요법 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4927571A (en) * | 1987-05-18 | 1990-05-22 | Liposome Technology, Inc. | Preparation of injectable doxorubicin/liposome suspension |
| US4863739A (en) | 1987-05-19 | 1989-09-05 | Board Of Regents, The University Of Texas System | Liposome compositions of anthracycline derivatives |
| IS1685B (is) * | 1990-12-11 | 1998-02-24 | Bracco International B.V. | Aðferð við að búa til fitukúlur (liposomes) sem eru gæddar auknum hæfileika til að draga í sig og halda í sér aðskotaefnum |
| US5902604A (en) * | 1995-06-06 | 1999-05-11 | Board Of Regents, The University Of Texas System | Submicron liposome suspensions obtained from preliposome lyophilizates |
| WO2001032145A1 (en) * | 1999-10-29 | 2001-05-10 | Board Of Regents, The University Of Texas System | Method of cancer treatment |
| EP2314285B2 (en) * | 2003-02-14 | 2019-09-18 | Children's Hospital & Research Center at Oakland | Lipophilic drug delivery vehicle and methods of use thereof |
| PL2544537T3 (pl) * | 2010-03-10 | 2017-10-31 | Cempra Pharmaceuticals Inc | Pozajelitowe preparaty antybiotyków makrolidowych |
| WO2013055874A2 (en) * | 2011-10-14 | 2013-04-18 | Genentech, Inc. | Uses for and article of manufacture including her2 dimerization inhibitor pertuzumab |
| EP3572071A1 (en) * | 2011-10-21 | 2019-11-27 | Jazz Pharmaceuticals Research LLC | Lyophilized liposomes |
| US8926994B2 (en) | 2011-12-07 | 2015-01-06 | The Methodist Hospital Research Institute | Mesoporous silicon particles for the presentation of tumor antigens and adjuvant for anti-cancer immunity |
| ES2771926T3 (es) | 2014-09-13 | 2020-07-07 | Novartis Ag | Terapias de combinación |
| AU2015327868A1 (en) | 2014-10-03 | 2017-04-20 | Novartis Ag | Combination therapies |
| CN107569508A (zh) * | 2016-07-05 | 2018-01-12 | 江苏竞诺择生物医药科技有限公司 | 一种治疗造血系统增殖性疾病的药用组合物 |
| WO2018048752A1 (en) | 2016-09-09 | 2018-03-15 | Irisys, Inc. | Lipsomal anticancer compositions |
| WO2019023873A1 (zh) * | 2017-07-31 | 2019-02-07 | 江苏竞诺择生物医药科技有限公司 | 一种用于治疗造血系统增殖性疾病的纳米脂质微粒组合物及药用组合物 |
| MA53565A (fr) | 2018-09-04 | 2021-07-14 | Minerva Neurosciences Inc | Procédés d'utilisation d'un composé phénoxypropylamine pour le traitement de la douleur |
| ES3049663T3 (en) | 2019-06-28 | 2025-12-17 | Univ Texas | Method of reconstituting liposomal annamycin |
| KR20220027969A (ko) | 2019-06-28 | 2022-03-08 | 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 | 프리리포솜 아나마이신 동결건조물의 제조 |
| KR20220103992A (ko) | 2019-11-21 | 2022-07-25 | 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 | 리포솜 아나마이신에 의한 폐 표적화 항암 요법 |
-
2020
- 2020-06-25 ES ES20832031T patent/ES3049663T3/es active Active
- 2020-06-25 WO PCT/US2020/039621 patent/WO2020264161A1/en not_active Ceased
- 2020-06-25 AU AU2020302784A patent/AU2020302784A1/en active Pending
- 2020-06-25 CN CN202080048890.7A patent/CN114728101B/zh active Active
- 2020-06-25 EP EP20832031.7A patent/EP3990041B1/en active Active
- 2020-06-25 MX MX2021015667A patent/MX2021015667A/es unknown
- 2020-06-25 CA CA3144443A patent/CA3144443A1/en active Pending
- 2020-06-25 BR BR112021026480A patent/BR112021026480A2/pt unknown
- 2020-06-25 KR KR1020227000486A patent/KR20220027941A/ko active Pending
- 2020-06-25 CN CN202310738252.3A patent/CN116785242A/zh active Pending
- 2020-06-25 JP JP2021577862A patent/JP7830131B2/ja active Active
- 2020-06-25 SG SG11202113005SA patent/SG11202113005SA/en unknown
- 2020-06-25 PL PL20832031.7T patent/PL3990041T3/pl unknown
- 2020-06-29 TW TW113132623A patent/TW202500161A/zh unknown
- 2020-06-29 TW TW109121840A patent/TWI857086B/zh active
-
2021
- 2021-12-17 US US17/554,553 patent/US12257262B2/en active Active
- 2021-12-27 IL IL289433A patent/IL289433B1/en unknown
-
2023
- 2023-10-05 US US18/481,951 patent/US11980634B2/en active Active
-
2024
- 2024-05-29 AU AU2024203593A patent/AU2024203593B2/en active Active